Advancing Menopause Care and Mid-Life Women’s Health Act
The Advancing Menopause Care and Mid-Life Women's Health Act (HR 8223) establishes federal research, public health, and training initiatives to improve care for women experiencing perimenopause and menopause. It authorizes $25 million annually for research on menopausal symptoms and related health conditions like osteoporosis, mental health disorders, and chronic pain, plus $10 million each for public health promotion, awareness campaigns, and healthcare provider training programs. The bill creates Centers of Excellence in menopause care, requires a data dashboard tracking health outcomes, and mandates annual reports on barriers to care in underserved areas. It directly affects women experiencing menopause, healthcare providers, and institutions serving mid-life women. The legislation runs from fiscal years 2025 through 2029 with specific funding allocations for each component.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2024
Committee Review
Floor Vote
President
Introduced May 2, 2024
Last action May 10, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
May 10, 2024
Committee
Referred to the Subcommittee on Health.
lower
May 2, 2024
Committee
Referred to the House Committee on Energy and Commerce.
lower
May 2, 2024
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8223
Scope: US
Hi! I can help you understand HR 8223. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline